Get started
Author

Francesco Amorelli

Observed name: F. Amorelli
ORCID: 0009-0009-4833-8629
Observed ORCID: 0009-0009-4833-8629
OpenAlex ID: A5060891908
Landscape of Biomarkers and Pathologic Response in Rectal Cancer: Where We Stand?
2024 · Abrahams Ocanto, Macarena Teja, et al. · Cancers · 6
PDF
Machine learning-based automated planning for hippocampal avoidance prophylactic cranial irradiation
2022 · Rodríguez de Dios N, Martínez Moñino A, et al. · Clinical & Translational Oncology · 4
Diagnostic Capability and Improved Clinical Management of 18F-DCFPyL-PSMA PET/CT in Occult Biochemical Recurrence of Prostate Cancer After Prostatectomy
2025 · Francesco Amorelli, Palmira Foro, et al. · Cancers · 3
PDF
A Phase II Trial of Intraoperative Radiotherapy after Surgical Resection of Brain Metastases: Feasibility and Efficacy NCT04847284
2023 · P. Foro, A. Narvaez, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Impact of 18F-DCFPyL-PSMA PET/CT on Radiotherapy Planning and Treatment Intensification in Occult Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
2026 · Francesco Amorelli, Pedro Plaza, et al. · Cancers
3376 Intraoperative Radiotherapy after surgical resection of Brain Metastases: Feasibility and Efficacy. NCT
2025 · Palmira Foro, Francesco Amorelli, et al. · Radiotherapy and Oncology
4244 Biochemical response after metabolic imaging-guided radiotherapy PSMA-1007 in biochemical recurrence of prostate cancer after radical prostatectomy
2025 · Francesco Amorelli, Pedro Jose Plaza, et al. · Radiotherapy and Oncology
2963 Shift in radiotherapy planning from original to post-PSMA intent-to-treat in patients with biochemical recurrence of prostate cancer
2025 · Francesco Amorelli, Pedro Jose Plaza, et al. · Radiotherapy and Oncology
1434: Clinical utility and impact on the therapeutic management of PET 18F-PSMA DCFPyL in prostate cancer
2024 · Francesco Amorelli, Pedro J. Plaza, et al. · Radiotherapy and Oncology
1444: Diagnostic capacity of 18F-PSMA DCFPyL in biochemical relapse of prostate cancer with low PSA values
2024 · Francesco Amorelli, Palmira Foro, et al. · Radiotherapy and Oncology
Change in Therapeutic Approach after PET/TC PSMA-18F DCFPyL in Occult Biochemical Recurrence of Prostate Carcinoma with Low PSA Values
2023 · F. Amorelli, P. Plaza, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Diagnostic Utility of PSMA 18F-DCFPyL PET/TC in Occult Biochemical Recurrence of Prostate Carcinoma with PSA Values <2ng/ml More than Two Years of Experience
2023 · F. Amorelli, P. Foro, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Impact of Lymphopenia on Treatment Outcomes in Unresectable Non-Small Cell Lung Cancer
2023 · F. Amorelli, A. Martinez, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
¿Cuándo hay que irradiar los ganglios después de cirugía primaria?
2023 · Manuel Algara, Nuria Rodríguez de Dios, et al. · Revista de Senología y Patología Mamaria
Works count: 14
Citation count: 14
H-index: 3
I10-index:
Year
Topic
Type